American Journal of Medicine and Medical Sciences

p-ISSN: 2165-901X    e-ISSN: 2165-9036

2025;  15(7): 2322-2327

doi:10.5923/j.ajmms.20251507.50

Received: Apr. 28, 2025; Accepted: May 22, 2025; Published: Jul. 23, 2025

 

Our Method of Surgical Treatment of Patellar Chondromalacia

Irismetov M. E.1, Shamshimetov D. F.2, Irismetov D. M.2, Tadjinazarov M. B.2, Rustamov F. R.2

1Republican Specialized Scientific and Practical Medical Center of Traumatology and Orthopedics, Tashkent, Uzbekistan

2Sport Travma, Republican Specialized Scientific and Practical Medical Center of Traumatology and Orthopedics, Tashkent, Uzbekistan

Correspondence to: Irismetov D. M., Sport Travma, Republican Specialized Scientific and Practical Medical Center of Traumatology and Orthopedics, Tashkent, Uzbekistan.

Email:

Copyright © 2025 The Author(s). Published by Scientific & Academic Publishing.

This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/

Abstract

Patellofemoral pain syndrome is one of the most frequent symptom complexes encountered in the reception of traumatologists, neurologists, rehabilitation specialists, medical physical culture specialists, and sports medicine specialists. With the development of Ortho biology, interest in regenerative medicine increases. Subchondral use of PRP therapy in chondromalacia of the patella is completely unexplored. We conducted arthroscopic diagnosis and treatment of 159 patients between 2020 and 2024, of whom 113 (71.1%) were women and 46 (28.9%) were men. The average age of patients was 50.4±7.3 years. The patients were divided into two groups. First control group, 86 (54.1%) patients, second main group consisted of 73 patients (45.9%), all patients underwent lavage and knee joint debridement, mobilized the lateral edge of the patella, and released the outer retainer. To stabilize, the ablation of the weighted part of the knee joint surface was performed. The same operation and subchondral plasma lifting were performed in the main group. Before surgery, 1, 3, 6, and 12 months after surgery, the knee joint was assessed using the IKDC and VAS scales. Patients were subjected to radiography, ultrasound, knee joint MRI before surgery, and controlled knee joint MRI after surgery. The patients of the main group showed good results in the near term according to the ICDS scale (78,4±5,2-80,3±6,5). In the long term, very good results were obtained (88.5±8.5). In this case, similar results were also noted on the VAS scale (1.5±0.1-1.0±0.18). The lavage and debridement of the entire joint and especially the outer fascia, as well as the mobilization of the lateral edge of the patella and the release of the outer retainer, ensure the mobile and free movement of the patella, thereby reducing inflammatory changes.

Keywords: Patellar chondromalacia, Patellofemoral pain syndrome, Platelet-Rich Plasma

Cite this paper: Irismetov M. E., Shamshimetov D. F., Irismetov D. M., Tadjinazarov M. B., Rustamov F. R., Our Method of Surgical Treatment of Patellar Chondromalacia, American Journal of Medicine and Medical Sciences, Vol. 15 No. 7, 2025, pp. 2322-2327. doi: 10.5923/j.ajmms.20251507.50.

1. Introduction

The patella is the largest sesamoid bone in the body, and its articular surface is covered with thick cartilage. The patella engages with the femoral groove at approximately 10-15 degrees of flexion and remains engaged throughout the entire range of knee flexion [1].
Articular cartilage is a highly specialized connective tissue with biophysical properties that enable it to withstand high compressive loads. The biochemical properties and structure of the macromolecular components of the cartilage matrix, along with their interaction with water molecules, are key factors determining the shock-absorbing properties of the tissue [2,3].
Chondromalacia is a disease of the hyaline cartilage that covers the articular surfaces of bones. It leads to softening and subsequent rupture, cracking, and erosion of the hyaline cartilage. Most often, it affects the mechanism of knee joint extension and, accordingly, is often called chondromalacia patellae, patellofemoral syndrome, or "runner's knee." The lower surface of the patella is covered with hyaline cartilage, which articulates with the femoral groove covered with hyaline cartilage (trochlear groove). Post-traumatic injuries, microtraumas, wear and tear, and iatrogenic drug injections can lead to the development of chondromalacia [4].
Women are more susceptible to this condition than men, which is attributed to the increased Q-angle in women. Apparently, there are no hormonal causes for this disease. Chondromalacia is more common in active young people who engage in running, or in workers who increase the load on the patellofemoral joint by frequently climbing stairs and/or kneeling [5].
Treatment of patients with chondromalacia patellae is a complex task, as there is no single universally accepted form of treatment that would be considered the standard of care. Treatment should be based on the results of a medical examination. It may include patellar braces, physiotherapy to strengthen the quadriceps femoris muscle, orthopedic insoles that reduce foot pronation, and non-steroidal anti-inflammatory drugs. Sometimes, platelet-rich plasma (PRP) therapy is recommended, but this is not a standard of care. It has not been proven that PRP therapy consistently improves patients' condition. Similarly, some authors recommend prolotherapy, but it is not a standard treatment and has not proven its effectiveness [4].
Despite the existence of several effective surgical methods, the patient's age and severity of the condition should be taken into account when selecting the most appropriate approach. Each method has its own advantages, indications, and limitations. Available techniques include patellar excision, cartilage removal, drilling, tibial tuberosity osteotomy, tibial tuberosity anteversion and elevation, partial or complete patellectomy, proximal soft tissue repair, and distal patellar bone repair. The most effective and straightforward procedure that avoids fibrosis and dysfunction of the quadriceps femoris muscle is medial realignment of the patellar tendon with lateral release and tensioning of the medial portion of the quadriceps femoris muscle [8].
Patella replacement. The McKeever prosthesis initially showed positive long-term effects in cases of severe patellar chondromalacia with progressive patellofemoral osteoarthritis; however, this procedure was abandoned due to numerous complications, such as patellar tendon damage, secondary patellar fracture, avascular necrosis, patellofemoral joint instability, and prosthesis loosening [9,15].
Cellular therapy. [16,17]. The first report of autologous chondrocyte implantation for the treatment of cartilage defects in knee osteoarthritis was published in 1994 [18]. Over the past two decades, cellular therapy for osteoarthritis has become one of the established treatment methods. Many experts consider chondromalacia patellae to be a mesenchymal disorder; therefore, cellular therapy may have a positive therapeutic effect. New treatment approaches include autologous chondrocyte transplantation and mesenchymal stem cell injections.
For many years, arthroscopic mechanical debridement has demonstrated successful symptom relief by removing damaged and unstable cartilage to create a stable edge [19]. However, mechanical shavers can also have a "tearing" effect on the cartilage, posing a significant risk of iatrogenic damage to adjacent healthy cartilage and subsequent progression of the lesion [21,22]. Radiofrequency (RF) knee arthroplasty (ablation) has been proposed as a safe method to address the drawbacks associated with mechanical shaver use [21]. Previous studies have shown that using radiofrequency ablation can make the cartilage surface smoother, limit damage to surrounding healthy cartilage, and potentially reduce the frequency of iatrogenic injuries, in addition to shortening operation time and reducing intra-articular bleeding, which are its main advantages [22]. With the advent of radiofrequency energy for chondroplasty, both monopolar and bipolar systems have been incorporated into instrument development [23]. It has been demonstrated that bipolar radiofrequency systems can penetrate 78-92% deeper than monopolar frequency systems [24]. During radiofrequency procedures, surgeons generally fear chondrotoxic thermal damage, postoperative chondrolysis, and osteonecrosis of the adjacent subchondral bone [21,22,25].
Previous studies have evaluated the effects of bipolar and monopolar radiofrequency devices in vitro, although reports on in vivo effects and clinical outcomes are still relatively scarce [24]. The authors suggested that radiofrequency ablation leads to improved clinical outcomes with low rates of complications and repeat surgeries [26].
Objective. To improve the results of surgical treatment methods for grade II-III chondromalacia of the patella by optimizing and enhancing arthroscopic chondroplasty. To improve the results of surgical methods of treatment of II-III degree of chondromalacia of the patella by optimizing and improving arthroscopic chondroplasty.

2. Materials and Methods

In the Department of Sports Trauma at the Republican Specialized Scientific and Practical Medical Center of Traumatology and Orthopedics, we conducted arthroscopic diagnosis and treatment of 159 patients between 2020 and 2024, of whom 113 (71.1%) were women and 46 (28.9%) were men. Among the patients, 46 were under 18 years old, 17 were 19 to 30 years old, 14 were 31 to 40 years old, 30 were 41 to 50 years old, and 52 were 51 to 60 years old.
The patients were divided into two groups. In the first control group, 86 (54.1%) patients underwent lavage and debridement of the knee joint, mobilization of the lateral edge of the patella, and release of the external retainer. In order to stabilize, the hanging part of the articular surface of the patella was ablated.
The second main group consisted of 73 patients (45.9%) who had unfavorable results of conservative treatment and grade I-II-III chondromalacia. They performed lavage and debridement of the knee joint, mobilization of the lateral edge of the patella, and release of the external retainer. In order to stabilize, the hanging part of the articular surface of the patella was ablated. Subchondral plasm lifting was also performed.
The main complaints of most patients were aching or colicky pain in the knee joint, which intensified with physical exertion and changes in weather, as well as difficulty walking on uneven surfaces and stairs. The pains were sometimes diffuse, without clear localization.
Patients underwent radiography in three projections: frontal, sagittal, and axial. Ultrasound of the knee joint was performed using linear or convex transducers with a frequency of 5 to 10 MHz, while the leg was bent at the knee to 50°-60°-90°, with the transducer positioned over the joint space. Magnetic resonance imaging of the knee joint was also performed with 3 mm slices and a 1.5 Tesla magnetic field. MRI results were obtained in 3 planes: axial, coronal, and sagittal, and included T1 and T2 sequences, which identified grade II-III chondromalacia patellae (Fig. 1) and pathological patellar plicas (Fig. 2).
Figure 1. A, B - MRI image of grade II-III chondromalacia foci in the patella
Figure 2. A, B - MRI image of the pathological patellar fold
Patients underwent lavage and debridement of the knee joint, mobilization of the lateral edge of the patella, and release of the lateral retinaculum. To stabilize the joint, ablation of the hanging portion of the patellar articular surface was performed. Subchondral plasma lifting was carried out. In the majority of patients, pathological suprapatellar folds were identified in the upper chamber of the knee joint (Fig. 3), as well as grade II-III chondromalacia on the articular surface of the patella (Fig. 4).
Figure 3. A, B, C - Arthroscopic view of pathological folds of the patella
Figure 4. А, B, C – Arthroscopic view of patellar chondromalacia
Operation technique. The operation was performed under anesthesia, which was selected based on the patient's sensitivity to drugs, indications, and operation time. Epidural, regional, local anesthesia, and occasionally general anesthesia were used. Under normal circumstances, the operation lasted about 1 hour. A tourniquet was applied to the patient's thigh to reduce blood flow in the joint. Two incisions were made in the knee area - anteromedial and anterolateral, 4-7 mm long, for the insertion of instruments and camera. A 0.9% NaCl physiological solution was introduced into the joint under pump pressure control. Diagnostic examination of the knee joint elements, lavage, and debridement of the entire joint, especially the lateral facet, were performed. The lateral edge of the patella was mobilized using an arthroscopic shaver and ablator, and the lateral retinaculum was released (Fig. 5). Next, ablation of the hanging part of the articular surface of the patella was performed (Fig. 6), followed by repeated joint lavage. The focus of chondromalacia on the articular surface of the patella was detected using a probe. A 0.5 cm incision was made above the patella in the projection of the chondromalacia site. Using 1.0 mm diameter wires under fluoroscopic control, the subchondral zone was reached, and pre-prepared plasma (plasma lifting) was injected subchondral, considering the affected chondromalacia area, from 0.5 to 1.0 ml (Fig. 7). The incisions were sutured and sterile dressings were applied. A compression bandage and an immobilizing splint were applied to the knee, and ice was applied.
Figure 5. A, B, C - Arthroscopic view of the lateral facet debridement and release of the lateral patellar retinaculum
Figure 6. A, B, C, D - Arthroscopic view of the ablation of the suspended portion of the patellar articular surface
Figure 7. Image of subchondral plasma lifting of the patella
Plasma preparation technique. Blood was collected in a sterile 10 ml syringe, which was pre-filled with an anticoagulant based on sodium citrate with glucose. The blood was mixed with the anticoagulant and transferred to one or two syringe tubes. These tubes were then placed in a centrifuge. A specially designed centrifuge with a gentle (soft) centrifugation mode (620 g, 12 minutes) was used. Afterwards, using a 5 ml or 3 ml syringe, a layered extraction of plasma and "Buffy Coat" was performed from the syringe tubes, including the surface part of the erythrocyte layer, which contained young, most active platelets and monocytes.
During centrifugation of 10 ml of blood, the first layer obtained was norm plasma, which is about 3 milliliters of the upper plasma. The remaining 2 milliliters with the "Buffy Coat," containing approximately 1,000,000 platelets per 1 μL, were used for PRP.

3. Results and Discussion

Our proposed method of chondroplasty for the articular surface of the patella includes the elimination of cartilage defects. The method demonstrated successful symptom relief by stabilizing the damaged and unstable cartilage with the formation of a stable edge. Radiofrequency ablation makes the cartilage surface smoother, limits damage to surrounding healthy cartilage, and potentially reduces the frequency of iatrogenic injuries. Additionally, it shortens operation time and reduces intra-articular bleeding, which are its main advantages.
All patients underwent early postoperative rehabilitation measures according to a prescribed scheme following chondroplasty of the articular surface of the patella. The average duration of the rehabilitation process was 2-3 months. The average time to return to sports activities was 3-4 months.
At 1-, 3-, 6-, and 12-months post-surgery, the knee joint was evaluated using the IKDC and VAS scales (Table 1,2).
Table 1. The results of the control group
     
When evaluating patients in the control group according to the ICDS scale, after 1 month there was a sharp improvement from 50.5±4.1 to 82.2±5.2. However, in the long-term results, a deterioration of 79.3±8.4 was observed. Similar results were noted on the VAS scale (from 3.5±0.26 to 1.3±0.25 and 1.8±0.21).
Table 2. The results of the main group
     
The patients of the main group showed good results in the near term according to the ICDS scale (78,4±5,2-80,3±6,5). In the long term, very good results were obtained (88.5±8.5). In this case, similar results were also noted on the VAS scale (1.5±0.1-1.0±0.18).
An analysis of the results showed that the patients in the control group showed very good results in the near term, especially after 1 month, but this effect did not persist after 6 and 12 months. The immediate results of patients in the main group, that is, after 1 month, are worse than in the control group, but the results after 3, 6 months are better, and this effect persists in the long term. Based on this, we can say that the effectiveness of the subchondral PRP used in the main group is felt after 1 month, and after 6 months it reaches high efficiency and remains in the long term.

4. Conclusions

Our proposed method of chondroplasty of the patellar articular surface using a low-frequency ablator demonstrated advantages in reducing pain syndrome by stabilizing the damaged and unstable cartilage, forming a stable edge and a smoother cartilage surface.
Despite the obtained results and the proven effectiveness and safety of subchondral PRP administration in treating grade II-III patellar chondromalacia, we consider it necessary to conduct further research to study this pathology.
Our performed lavage and debridement of the entire joint, especially the lateral facet, as well as mobilization of the lateral patellar edge and release of the lateral retinaculum, ensured mobile and free movement of the patellar articular surface, thereby reducing inflammatory changes.

References

[1]  Stephen R. Christian, MD, M. Bret Anderson, MD, Ronald Workman, MD, William F. Conway, MD, FACR, Thomas L. Pope, MD // Imaging of Anterior Knee Pain// Department of Radiology, Medical University of South Carolina, PO Box 250322.
[2]  169 Ashley Avenue, Charleston, Clin Sports Med 25 (2006) 681–702 // doi:10.1016/j.csm.2006.06.010.
[3]  Harpal K. Gahunia MSc, PhD, Kenneth P.H. Pritzker // Effect of Exercise on Articular Cartilage // Orthopedic Clinics of North America Volume 43, Issue 2, April 2012, Pages 187-199 // doi.org/10.1016/j.ocl.2012.03.001.
[4]  Z.A Cohen Ph.D, V.C Mow Ph.D, J.H Henry M.D, W.N Levine M.D, G.A Ateshian Ph.D // Templates of the cartilage layers of the patellofemoral joint and their use in the assessment of osteoarthritic cartilage damage // Osteoarthritis and Cartilage Volume 11, Issue 8, August 2003, Pages 569-579 //doi.org/10.1016/S1063-4584(03)00091-8.
[5]  Steven F. Habusta; Ryan Coffey; Subitchan Ponnarasu; Ahmed Mabrouk; Edward E. Griffin // Chondromalacia Patella // Treasure Island (FL): StatPearls Publishing; 2024 Jan- // Bookshelf ID: NBK459195PMID: 29083563.
[6]  Zhang H, Kong XQ, Cheng C, Liang MH. A correlative study between prevalence of chondromalacia patellae and sports injury in 4068 students. Chin J Traumatol. 2003 Dec; 6(6): 370-4 // PMID: 14642059.
[7]  Bakhtiary AH, Fatemi E. // Open versus closed kinetic chain exercises for patellar chondromalacia. // Br J Sports Med. 2008 Feb; 42(2): 99-102; discussion 102 // DOI: 10.1136/bjsm.2007.038109.
[8]  Petersen W, Ellermann A, Rembitzki IV, Scheffler S, Herbort M, Brüggemann GP, Best R, Zantop T, Liebau C. // Evaluating the potential synergistic benefit of a realignment brace on patients receiving exercise therapy for patellofemoral pain syndrome: // a randomized clinical trial. Arch Orthop Trauma Surg. 2016 Jul; 136(7): 975-82. // DOI: 10.1007/s00402-016-2464-2.
[9]  Zheng W, Li H, Hu K, Li L, Bei M. // Chondromalacia patellae: current options and emerging cell therapies. // Stem Cell Res Ther. 2021 Jul 18; 12(1): 412. // DOI: 10.1186/s13287-021-02478-4.
[10]  Zha GC, Feng S, Chen XY, Guo KJ. // Does the grading of chondromalacia patellae influence anterior knee pain following total knee arthroplasty without patellar resurfacing? // Int Orthop. 2018 Mar; 42(3): 513-518 // DOI: 10.1007/s00264-017-3658-0.
[11]  Dehaven KE, Dolan WA, Mayer PJ // Chondromalacia patellae in athletes // Clinical presentation and conservative management // Am J Sports Med. 1979 Jan-Feb; 7(1): 5-11 // DOI: 10.1177/036354657900700102.
[12]  Tseng TH, Tsai YC, Lin KY, Kuo YK, Wang JH // The correlation of sagittal osteotomy inclination and the anteroposterior translation in medial open-wedge high tibial osteotomy-one of the causes affecting the patellofemoral joint? // Int Orthop. 2019 Mar; 43(3): 605-610 // DOI: 10.1007/s00264-018-3951-6.
[13]  Cavaignac E, Pailhé R, Reina N, Wargny M, Bellemans J, Chiron P. // Total patellectomy in knees without prior arthroplasty: a systematic review // Knee Surg Sports Traumatol Arthrosc. 2014 Dec; 22(12): 3083-92 // DOI: 10.1007/s00167-014-3012-7.
[14]  Fujimura K, Sakuraba K, Kamura S, Miyazaki K, Kobara N, Terada K, Miyahara H // Reconstruction of Acute Patellar Tendon Rupture after Patellectomy // Case Rep Orthop. 2018; 2018: 7549476 // DOI: 10.1155/2018/7549476.
[15]  Hiemstra LA, Frizzell B, Kerslake S// Medial Quadriceps Tendon Femoral Ligament Reconstruction After Patellectomy: A Treatment for a Dislocating Quadriceps Tendon // J Am Acad Orthop Surg Glob Res Rev. 2017 Mar; 1(1): e001 // DOI: 10.5435/JAAOSGlobal-D-17-00001.
[16]  Harrington KD // Long-term results for the McKeever patellar resurfacing prosthesis used as a salvage procedure for severe chondromalacia patellae // Clin Orthop Relat Res. 1992 Jun; (279): 201-13 // pubmed.ncbi.nlm.nih.gov/1600657.
[17]  Steinert AF, Ghivizzani SC, Rethwilm A, Tuan RS, Evans CH, Nöth U // Major biological obstacles for persistent cell-based regeneration of articular cartilage // Arthritis Res Ther. 2007; 9(3): 213 // DOI: 10.1186/ar2195.
[18]  Freitag J, Bates D, Boyd R, Shah K, Barnard A, Huguenin L, Tenen A // Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a review// BMC Musculoskelet Disord. 2016 May 26; 17: 230 // DOI: 10.1186/s12891-016-1085-9.
[19]  Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L // Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation // N Engl J Med. 1994 Oct 06; 331(14): 889-95 // DOI: 10.1056/NEJM199410063311401.
[20]  Anderson, D.E. Rose, M.B. Ville, A.J // Arthroscopic mechanical chondroplasty of the knee joint is effective in the treatment of focal cartilage lesions in the absence of concomitant pathology // Orthop J Sports Med. 2017; 5, 2325967117707213 // pubmed.ncbi.nlm.nih.gov/28589161.
[21]  Kosy, J.D. ∙ Schranz, P.J. ∙ Toms, A.D. // The use of radiofrequency energy for arthroscopic chondroplasty in the knee // Arthroscopy. 2011; 27: 695-703 // pubmed.ncbi.nlm.nih.gov/21663725/.
[22]  Piper, D. ∙ Taylor, C. ∙ Howells, N. // Use of a novel variable power radiofrequency ablation system specific for knee chondroplasty: // Surgical experience and two-year patient results Cureus. 2021; 13, e12864 // doi.org/10.1177/2325967117707213.
[23]  Cetik, O. ∙ Cift, H. ∙ Comert, B. // Risk of osteonecrosis of the femoral condyle after arthroscopic chondroplasty using radiofrequency: A prospective clinical series// Knee Surg Sports Traumatol Arthrosc. 2009; 17: 24-29 // pubmed.ncbi.nlm.nih.gov/18758748/.
[24]  Shinmura, K. ∙ Ikematsu, H. ∙ Kojima, M. // Safety of endoscopic procedures with monopolar versus bipolar instruments in an ex vivo porcine model// BMC Gastroenterol. 2020; 20: 27 // pubmed.ncbi.nlm.nih.gov/32005163/.
[25]  Lu, Y. ∙ Edwards, 3rd, R.B. ∙ Cole, B.J. // Thermal chondroplasty with radiofrequency energy. An in vitro comparison of bipolar and monopolar radiofrequency devices // Am J Sports Med. 2001; 29: 42-49 //pubmed.ncbi.nlm.nih.gov/11206255/.
[26]  Cetik, O. ∙ Cift, H. ∙ Comert, B. // Risk of osteonecrosis of the femoral condyle after arthroscopic chondroplasty using radiofrequency: A prospective clinical series // Knee Surg Sports Traumatol Arthrosc. 2009; 17: 24-29 // pubmed.ncbi.nlm.nih.gov/18758748/.
[27]  Trevor Tuthill, B.S. Garrett R. Jackson, M.D. Sabrina F. Schundler, B.S // Radiofrequency Chondroplasty of the Knee Yields Excellent Clinical Outcomes and Minimal Complications: A Systematic Review 2023 The Authors. Published by Elsevier Inc. on behalf of the Arthroscopy Association of North America Received January 29, 2023; Accepted May 22, 2023; Published online July 17, 2023 // DOI: 10.1016/j.asmr.2023.05.006.